
Editors at The Lancet Oncology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from early-stage breast cancer treatment to mRNA vaccines, the access to essential cancer medicines for children to measuring ovarian toxicit... more
| Publishes | Monthly | Episodes | 214 | Founded | 6 years ago |
|---|---|---|---|---|---|
| Number of Listeners | Categories | MedicineHealth & Fitness | |||

Jamie Prowse, Senior Editor at The Lancet Oncology, is joined by Dr Hedvig Hricak (Memorial Sloan Kettering Cancer Center, New York, NY, USA) and Dr Zachary Ward (Harvard TH Chan School of Public Health, Boston, MA, USA) to discuss Cancer workforce—a... more
Cheryl Lai, Acting Deputy Editor of The Lancet Oncology, is joined by Professor Fred Saad (Department of Surgery/Urology, University of Montreal, Montreal, QC, Canada) to discuss pain and health-related quality-of-life outcomes from the randomised ph... more
Cheryl Reeves, Senior Editor at The Lancet Oncology, is joined by Professor James Nagarajah to discuss his open-label, randomised, phase 2 study [177Lu]-PSMA-617-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE).
Click here to... more
Join us for this special episode where Deputy Editor Cheryl Lai speaks with Ali Landman, Editor-in-Chief of The Lancet Medical Imaging & Theranostics, about the scope and vision of the new journal and Ali's highlights in oncological imaging from the ... more
People also subscribe to these shows.




How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.
Apple Podcasts | #12 | |
Apple Podcasts | #65 | |
Apple Podcasts | #69 | |
Apple Podcasts | #174 | |
Apple Podcasts | #183 | |
Apple Podcasts | #250 |
Recent interactions between the hosts and their guests.
Listeners, social reach, demographics and more for this podcast.
| Listeners per Episode | |
|---|---|
| Gender Skew | |
| Location | |
| Interests | |
| Professions | |
| Age Range | |
| Household Income | |
| Social Media Reach |
This show features interviews with leading cancer researchers, clinicians, and editors, drawing out the practical implications of the latest oncology research for patients, care delivery, and health policy. Episodes often center on trial results, novel therapies, cancer imaging and diagnostics, and the human dimensions of cancer care, with hosts who are editors or researchers from The Lancet Oncology guiding the conversation. A standout strength is the breadth of topics—from prostate cancer outcomes and radioligand therapy to global cancer burden, qualitative research in oncology, and imaging-driven advances—paired with a clear eye toward how new evidence translates into better patient outcomes and system-level improvements. The format tend... more
Rephonic provides a wide range of podcast stats for The Lancet Oncology in conversation with. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to The Lancet Oncology in conversation with and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.
Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for The Lancet Oncology in conversation with, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.
Rephonic provides comprehensive predictive audience data for The Lancet Oncology in conversation with, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.
To see how many followers or subscribers The Lancet Oncology in conversation with has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.
These podcasts share a similar audience with The Lancet Oncology in conversation with:
1. NEJM This Week
2. JAMA Editors' Summary
3. Harrison's PodClass: Internal Medicine Cases and Board Prep
4. JAMA Medical News
5. Journal of Clinical Oncology (JCO) Podcast
The Lancet Oncology in conversation with launched 6 years ago and published 214 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.
Rephonic pulls ratings and reviews for The Lancet Oncology in conversation with from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.
View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.
Rephonic provides full transcripts for episodes of The Lancet Oncology in conversation with. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.
Recent guests on The Lancet Oncology in conversation with include:
1. Fred Saad
2. James Nagarajah
3. Ali Landman
4. Kayleigh Bhangdia
5. Dr. Jesse Plascak
6. Dr. Marissa Baker
7. Dr. Gary Rodin
8. Dr. Matthias Preusser
To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.